Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTR20161023Phase 3Active
A Phase 3 trial of tebipenem in community-acquired pneumonia (CAP), sponsored by Jiangsu Kefeiping Pharmaceutical Co., Ltd.. Started Dec 2016; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on CTR20161023.